14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BCEL
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Atreca Inc. stock price on Monday moving between $0.0751 and $0.0850
(Updated on Apr 22, 2024)

Sell candidate since Mar 27, 2024 Gain 13.33% PDF

The Atreca Inc. stock price gained 10.39% on the last trading day (Monday, 22nd Apr 2024), rising from $0.0770 to $0.0850. During the last trading day the stock fluctuated 13.18% from a day low at $0.0751 to a day high of $0.0850. The price has risen in 5 of the last 10 days and is up by 3.53% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 652 thousand more shares were traded than the day before. In total, 666 thousand shares were bought and sold for approximately $56.62 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BCEL Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, March 20, 2024, and so far it has risen 37.10%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Atreca Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Atreca Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.118. On a fall, the stock will find some support from the short-term average at $0.0791. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Atreca Inc. stock

Atreca Inc. finds support from accumulated volume at $0.0821 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0099 between high and low, or 13.18%. For the last week, the stock has had daily average volatility of 8.69%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BCEL) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Atreca Inc. to open at $0.0817, and during the day (based on 14 day Average True Range), to move between $0.0708 and $0.0992, which gives a possible trading interval of +/-$0.0142 (+/-16.69%) up or down from last closing price. If Atreca Inc. takes out the full calculated possible swing range there will be an estimated 33.39% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $0.0821, some $0.0029 (3.41%) from the current price of $0.0850, our system finds the risk reward attractive.

Is Atreca Inc. stock A Buy?

Atreca Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.431 Sell Candidate Unchanged

Predicted Opening Price for Atreca Inc. of Tuesday, April 23, 2024

Fair opening price April 23, 2024 Current price
$0.0817 ( 3.88%) $0.0850

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BCEL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0916 7.76 %
R2 0.0878 3.32 %
R1 0.0855 0.567 %
Current price: 0.0850
Support S1 0.0779 -8.33 %
S2 0.0756 -11.08 %
S3 0.0718 -15.53 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 0.0850
Support S1 0.0821 -3.41%
S2 0.0800 -5.88%
S3 0.0721 -15.18%

FAQ

What is the symbol for Atreca Inc. Stock and on which exchange is it traded?
The symbol for Atreca Inc. is BCEL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Atreca Inc. Stock?
Atreca Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Atreca Inc. Stock?
Atreca Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Atreca Inc. Stock.

What's the current price of Atreca Inc. Stock?
As of the end of day on the Apr 22, 2024, the price of an Atreca Inc. (BCEL) share was $0.0850.

What is the 52-week high and low for Atreca Inc. Stock?
The 52-week high for Atreca Inc. Stock is $1.26 and the 52-week low is $0.0520.

What is the market capitalization of Atreca Inc. Stock?
As of the Apr 22, 2024, the market capitalization of Atreca Inc. is 3.368M.

When is the next earnings date for Atreca Inc.?
The upcoming earnings date for Atreca Inc. is May 08, 2024.
Click to get the best stock tips daily for free!

About Atreca Inc.

Atreca. Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, ... BCEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT